title: [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
abstract: It's due to extraocular tissues enlargement: extraocular muscles. Thyroid stimulating receptor antibodies were first incriminated. However, Graves' proptosis can appear several months or years before development of goiter or thyrotoxicosis. Different treatment are possible: glucocorticoids, radiotherapy, surgical orbitary decompression, classical surgery. Treatment of hyperthyroidism has to be undertaken similarly. Classically, surgical or medical treatment with antithyroid drugs were indicated.
authors.affiliation: Service de Médecine Interne B, Hôpital Charles Nicolle, Tunisie.
authors.forename: Myrvat
authors.initials: M
authors.lastname: Kamoun
authors.forename: Hafaoua
authors.initials: H
authors.lastname: Abid
authors.forename: Faïza
authors.initials: F
authors.lastname: Lamine
authors.forename: Hédia
authors.initials: H
authors.lastname: Slimane
authors.forename: Ali
authors.initials: A
authors.lastname: Haddad
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006111:Graves Disease / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage / Q000627:therapeutic use; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014792:Visual Acuity
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D014662:Vasoconstrictor Agents; D008776:Methylprednisolone Hemisuccinate; D015282:Octreotide; D011241:Prednisone